Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
424studies shown
Showing 101-125 of 424
Not Yet RecruitingNCT05440955

tDCS for Cognitive Impairment Associated With Recent-onset Schizophrenia

This observational study is following people with Schizophrenia or psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
France
Sponsor
University Hospital, Grenoble
Condition
Schizophrenia
RecruitingNCT03886584

Source Monitoring Déficit in Neuropsychiatric Population

This study is looking at care and outcomes for people with mental health conditions. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

Mental healthOtherFrom 18 Years to 80 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Mental health
RecruitingNCT07396623

Validation of French PHQ-4 and PC-PTSD-5 Screening Scales

This observational study is following people with Mental Illness to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

Mental healthOtherOver 18 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Mental health
RecruitingNCT07202507

Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department

This study is looking at whether a digital support tool can help people with Snoezelen, Pediatric Cancer, Symptomatologie Anxieuse, or Chimiothérapie. Participants receive a study treatment and complete follow-up visits and assessments.

AnxietyOtherFrom 8 Years to 18 Years
Countries
France
Sponsor
Centre Oscar Lambret
Condition
Anxiety
Active Not RecruitingNCT03821779

Prefrontal Oscillations in Social Anxiety Disorder (POSAD)

This study is looking at whether a digital support tool can help people with anxiety or Anxiety and Fear. Participants take part in a digital support tool and complete follow-up assessments.

AnxietyOtherFrom 20 Years to 50 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Anxiety
RecruitingNCT07424404

A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively

This study is looking at care and outcomes for people with Schizophrenia or Autism-Related Irritability. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 5 Years to 17 Years
Countries
Canada, France, Germany, Hungary, Japan, Poland, Romania, Spain, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT06036316

Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis

This study is looking at care and outcomes for people with Psychosis, Schizophrenia, At-risk Mental State, or Language Disorders. Some participants may receive healthy controls instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 16 Years to 55 Years
Countries
France
Sponsor
Centre Psychothérapique de Nancy
Condition
Schizophrenia
RecruitingNCT06361407

Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia

This study is looking at care and outcomes for people with Schizophrenia or Sensory Processing Disorder. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Centre Psychothérapique de Nancy
Condition
Schizophrenia
RecruitingNCT06585787

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

This study is looking at how safe and effective KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD is for people with Alzheimer Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Argentina, Belgium, Brazil, Bulgaria, China, Croatia, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Poland, Portugal, United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, Ukraine
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Not Yet RecruitingNCT07446569

Perception and Integration of Sensory Information in the Early Stages of Psychosis

This study is looking at investigate the early sensory system in clinical high risk (CHR), first episode psychosis (FEP) individuals and heathly controls for people with Early Psychosis or Schizophrenia Prodromal. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 18 Years to 30 Years
Countries
France
Sponsor
Centre Psychothérapique de Nancy
Condition
Schizophrenia
Not Yet RecruitingNCT07375199

Reducing Mental Health Stigmatization Among Healthcare Workers and Students Using a Virtual Reality Protocol: The VIRTUS Protocol

This study is looking at whether a VR protocol simulating psychotic symptoms on explicit and implicit stigma works for people with Schizophrenia Disorder. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Centre Hospitalier Henri Laborit
Condition
Schizophrenia
RecruitingNCT04370730

Dimensional and Developmental Profiles of Psychosis in Children and Adolescents

This observational study is following people with Schizophrenia or psychosis to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherFrom 7 Years to 20 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Schizophrenia
RecruitingNCT07343193

Deprescribing Antipsychotics: a Multiple Case Study

This observational study is following people with psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
Not Yet RecruitingNCT07330843

Assessment and Evolution of Narrative Identity and Its Relationship to Subjective Multidimensional Well-being and Multidimensional Recovery in First Episode Psychosis

This observational study is following people with Psychosis or Mental Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 16 Years to 30 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Condition
Schizophrenia